To keep up with applications, FDA promotes new testing and administrative methods. At a time when healthcare costs are escalating and millions of Americans are uninsured, generic drugs have emerged as ...

Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars. Generic drugs account for nearly 90% of prescription drugs in the United States due to policies ...

Generic drugs are incredibly important in the medical field, not only for their effectiveness, but also for their cost-saving potential for both manufacturers and customers. Medication affordability ...

A look at how to develop a generic drug and the resources FDA supplies to Abbreviated New Drug Application applications. Over the past 35 years, the Food and Drug Administration’s (FDA) generic drug ...

The Generic Drug User Fee Amendments, designed to facilitate the delivery of safe and effective generic drugs to the public and improve the predictability of the ANDA assessment process, has undergone ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

TBIJ co-publishes its stories with major media outlets around the world so they reach as many people as possible. When a new drug enters the market, the manufacturer usually gets the exclusive right ...

We know you sometimes have burning questions that can best be answered by a pharmacist. Our feature, Ask Your Pharmacist, seeks to address some of those issues. Send your questions to ...

Hyderabad: Dr Reddy's Laboratories is positioning itself to enter the lucrative GLP-1 (glucagon-like peptide-1) drug market, with plans to launch generic versions of blockbuster diabetes and obesity ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ineffective has led to a rare response from the government. Doctors say they believe ...

Ottawa, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The global generic drug CRO market size is calculated at USD 8.74 billion in 2025 and is expected to reach around USD 11.73 billion by 2034, growing at a CAGR ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...